🇺🇸 FDA
Patent

US 10646543

Methods and compositions for treating trinucleotide repeat disorders

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 10646543 (Methods and compositions for treating trinucleotide repeat disorders) held by Sangamo Therapeutics, Inc. expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P